Abstract
PurposeHigh-grade B-cell lymphoma with MYC and BCL2 and/or BCL6 rearrangements (HGBL-DH/TH) has a poor outcome after standard chemoimmunotherapy. We s......
小提示:本篇文献需要登录阅读全文,点击跳转登录